Carregant...

Microsimulation Model Predicts Survival Benefit of Radiofrequency Ablation and Stereotactic Body Radiotherapy Versus Radiotherapy for Treating Inoperable Stage I Non–Small Cell Lung Cancer

OBJECTIVE: A subset of patients with stage IA and IB non–small cell lung cancer (NSCLC) is ineligible for surgical resection and undergoes radiation therapy. Radiofrequency ablation (RFA) and stereotactic body radiotherapy are newer potentially attractive alternative therapies. MATERIALS AND METHODS...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tramontano, Angela C., Cipriano, Lauren E., Kong, Chung Yin, Shepard, Jo-Anne O., Lanuti, Michael, Gazelle, G. Scott, McMahon, Pamela M.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3722903/
https://ncbi.nlm.nih.gov/pubmed/23617484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2214/AJR.12.8968
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!